Category Archives: Biotech

Clients in the News – Univ. of Cincinnati Find Panic Disorder Symptoms May Be Tied to Acid-Sensing Receptor

Panic disorder is a syndrome characterized by spontaneous and recurrent episodes of incapacitating anxiety. It typically emerges during adolescence or early adulthood and can take an exhausting emotional and physical toll on the body. Physical symptoms can include heart palpitations, sweating and/or chills, trouble breathing and dizziness, nausea and even chest pain. While significant progress […]

Clients in the News – UCLA Increasing Cannabis Research With Newly Established Research Group

As cannabis use becomes legal in more and more states in the US, both for recreational and medical purposes, it is becoming necessary for more research into the drug. Currently in the US, 20% of the population have access to legal recreational marijuana use and 60% have access to legal medical marijuana. Unfortunately, even with […]

Clients in the News – UAB Cancer Research Center receives $14.5M in NCI Funding This Year

Last year, the University of Alabama at Birmingham Comprehensive Cancer Center was awarded a five-year, $29 million grant for the National Cancer Institute. The Cancer Center now receives nearly $6M a year in NCI core funding and will continue to do so through 2021. In addition to this core grant, UAB CCC has received over […]

Clients in the News – Frost & Sullivan Awards Akonni Biosystems for its Molecular Diagnostics Platform

Based on its recent analysis of microarrays in molecular diagnostics (MDx), Frost & Sullivan recognizes Akonni Biosystems, Inc. with the 2017 North America Frost & Sullivan Award for New Product Innovation. Akonni’s integrated MDx system, TruDiagnosis®, is revolutionizing the point-of-care molecular testing market by enabling target detection from a variety of sample types. TruDiagnosis® is […]

Clients in the News – Akonni Biosystems Wins NIH SBIR Grant for Pediatric Respiratory Disease Diagnostics

Akonni Biosystems said today that it has received a Phase I Small Business Innovation Research grant from the National Institutes of Health to develop molecular diagnostic tests for lower respiratory diseases in children. The award, worth $225,000 and administered by the National Institute of Allergy and Infectious Diseases, is specifically intended to support the development […]

Clients in the News – AstraZeneca, Merck & Co. in $8.5-Billion Oncology Collaboration

AstraZeneca and Merck & Co. announced on July 27, 2017 that they have entered a global strategic oncology collaboration to co-develop and co-commercialize AstraZeneca’s Lynparza (olaparib) for multiple cancer types. Lynparza is an oral poly ADP ribose polymerase (PARP) inhibitor for treating BRCA-mutated ovarian cancer in multiple lines of treatment. It was approved by FDA […]

Clients in the News – Immunomic Therapeutics Celebrates National Immunization Awareness Month

August is National Immunization Awareness Month and Rockville, MD based Immunomic is dedicated to raising awareness of the importance of receiving life-saving vaccines. Vaccines are recommended to people of all ages. Currently, vaccines protect against 26 diseases and remain the best defense against several serious diseases like measles and diphtheria. August is an ideal time […]

Clients in the News – Integrated BioTherapeutics Receives $6.6M Grant from NIAID

Integrated BioTherapeutics Inc., a Rockville, Md.-based a biotechnology company focused on the discovery of novel vaccines and therapies for emerging infectious diseases, has been awarded a $6.6m grant from the National Institute of Allergy and Infectious Diseases (NIAID). The funds will be used to develop a vaccine that can protect against all ebolaviruses. The research […]

Clients in the News – UMinn, 3D-bioprinted Patch Helps Heal Scarred Heart Tissue After Heart Attack

  When a person experiences a heart attack, blood flow to the heart muscle is lost and cells die. Since these heart muscle cells cannot be replaced, scar tissue forms in the heart, putting patients at risk for future heart failure or faulty heart function. Now, biomedical engineers from the University of Minnesota have created […]

Clients in the News – UCONN Researchers find Chili Pepper and Marijuana Calm the Gut

You wouldn’t think chili peppers and marijuana have much in common. But when eaten, both interact with the same receptor in our stomachs, according to a paper by UConn researchers published in the April 24 issue of the journal Proceedings of the National Academy of Sciences. The research could lead to new therapies for diabetes […]

Clients in the News – Saint Louis Univ. Scientists Take Aim at Diabetes, Obesity with Exercise in a Pill

  With a series of new grants, Saint Louis University researchers will tackle the twin epidemics of diabetes and obesity by tapping into the potential of two nuclear receptors that control muscle metabolism. The scientists will optimize two promising drug compounds, moving a step closer toward capturing the benefits of exercise in pill form. Thomas […]

Clients in the News – Baylor College and NIH: US Enrolls Volunteers in Large Test of Possible Zika Vaccine

U.S. health officials have begun enrolling volunteers for critical next-stage testing of an experimental vaccine to protect against Zika, the mosquito-borne virus that can cause devastating birth defects in pregnant women. The first volunteer was vaccinated Wednesday at Baylor College of Medicine in Houston, as the National Institutes of Health gears up for a two-part […]

Clients in the News – UVA – Artificial Pancreas Improves Blood Sugar Control in Young Kids

An artificial pancreas, which delivers insulin in an automated way to individuals with type 1 diabetes, appears to be safe and effective for use in children ages 5 to 8 years, a new study finds. Results will be presented Tuesday at the Endocrine Society’s 99th annual meeting in Orlando, Fla. The “smart” artificial pancreas system, […]

Clients in the News – AstraZeneca, Circassia Enter Strategic Collaboration for Respiratory Disease

AstraZeneca announced it has entered a strategic collaboration with Circassia Pharmaceuticals plc, a respiratory biopharmaceutical company, for the development and commercialisation of Tudorza and Duaklir* in the US. Tudorza and Duaklir are inhaled respiratory medicines for the treatment of chronic obstructive pulmonary disease (COPD). Tudorza was approved and launched in the US in 2012. Duaklir […]

Clients in the News – Princeton Researchers Develop Technique to Track Yellow Fever Virus Application

Researchers from Princeton University’s Department of Molecular Biology have developed a new method that can precisely track the replication of yellow fever virus in individual host immune cells. The technique, which is described in a paper published March 14 in the journal Nature Communications, could aid the development of new vaccines against a range of […]

Clients in the News – Georgia State Researcher Wins Grant to Develop Ebola Virus Drug

Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university’s Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a five-year, $4.1 million federal grant to develop a drug targeting Ebola virus. “We still lack any approved drugs to […]

Clients in the News – Stanford University: Antibody Fights 5 Types of Pediatric Brain Tumors

An immunotherapy successfully and safely treated five different types of aggressive pediatric brain tumors in mice, according to a new study from researchers at Stanford University School of Medicine. The antibody, called Hu5F9-G4, works against a cellular “don’t eat me” signal called CD47. The anti-CD47 antibody causes immune cells to surround and destroy tumors while […]

Clients in the News – UMD Develops New Method that Enables Creation of Better Therapeutic Antibodies

Antibodies are the foot soldiers of our immune system. These specialized, Y-shaped proteins attach to bacteria and viruses, where they either block the pathogen’s activity directly, or signal the immune system’s cells to destroy the invader. The second function–the ability to target invaders for destruction–makes antibodies a tempting target for cancer and disease therapies. But […]

Clients in the News – Frederick company pitches new device for deadly disease detection

  Sputum — a nasty mix of saliva and mucus — doesn’t come up in polite conversation. But it is key to testing for tuberculosis, one of the deadliest infectious diseases on the planet. “Last year, TB surpassed HIV as the single greatest killer of all infectious diseases, globally,” said Michael Reinemann, the director of […]

Clients in the News – UCLA: Nearly $9M in NHLBI Funding to Help Take Science Solutions to Heart

Thus far in 2017, the University of California Los Angeles has received over $6.8 million in funding from the National Heart Lung and Blood Institute (NHLBI). This funding has been awarded through multiple grants intended to support cardiovascular research. Some of the projects aimed at finding new scientific solutions to cardiovascular issues include: A study […]